☆ 4.2 Meeting Abstract

Safety and tolerability of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy: results from a phase 1 clinical trial

NEUROMUSCULAR DISORDERS (2019)

Get Full Text
Add to Collection

Journal

NEUROMUSCULAR DISORDERS
Volume 29, Issue -, Pages S124-S124

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.nmd.2019.06.311

Keywords

-

Categories

Clinical Neurology Neurosciences

Funding

  1. Wave Life Sciences Ltd., Cambridge, MA

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.